首页> 外国专利> Carbazoly compounds 1,2,3,4 - tetrahidrocarbazol replaced, useful as inhibitors of Fatty Acid Release mediated by sPLA2.Process for preparing Composite Application; intermediaries in these procedures; Pharmaceutical compositions comprising such Compound

Carbazoly compounds 1,2,3,4 - tetrahidrocarbazol replaced, useful as inhibitors of Fatty Acid Release mediated by sPLA2.Process for preparing Composite Application; intermediaries in these procedures; Pharmaceutical compositions comprising such Compound

机译:取代了咔唑化合物1,2,3,4-四氢咔唑,用作sPLA2介导的脂肪酸释放抑制剂。这些程序中的中介;包含此类化合物的药物组合物

摘要

These are new tricyclic compounds application in inhibition of sPLA2 mediated release of Fatty Acids, such as Septic shock.These compounds are the Formulae (i) and (ii) wherein: Z is ciclohexenilo or phenyl Substituent; R21 is a non interfering; R21 is a group and a hydroxyl group or nhnh2 r2es MR5, - (CH2)Where R5 has the values indicated in the description. These objectives are also mentioned in the title of the application.
机译:这些是新的三环化合物,可用于抑制sPLA2介导的脂肪酸的释放,如败血性休克。 R21是无干扰的; R 21为基团和羟基或nhnh 2 r 2为MR 5-(CH 2),其中R 5具有描述中所指示的值。在申请书的标题中也提到了这些目标。

著录项

  • 公开/公告号AR018186A1

    专利类型

  • 公开/公告日2001-10-31

    原文格式PDF

  • 申请/专利权人 ELI LILLY AND COMPANY;

    申请/专利号AR1999P101770

  • 发明设计人

    申请日1999-04-16

  • 分类号C07D209/82;C07D401/04;C07D401/06;C07D405/04;C07D409/04;C07F7/18;A61K31/403;A61K31/44;A61K31/38;

  • 国家 AR

  • 入库时间 2022-08-22 01:26:19

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号